F. Parodi

Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study

D. Centonze, G. Marfia, M. Rovaris, 2023, Journal of Neurology.